Literature DB >> 10677411

Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

M Iemura1, M Ishii, T Sugimura, T Akagi, H Kato.   

Abstract

OBJECTIVES: To investigate the long term consequences of regressed aneurysms after Kawasaki disease, using follow up coronary angiography; to assess the vascular wall morphology at the site of the aneurysms by intravascular ultrasound imaging; and to evaluate the function of the affected vessels using intracoronary infusions of acetylcholine and isosorbide dinitrate.
DESIGN: 33 patients were studied, 27 with previous Kawasaki disease and six with congenital heart disease. All Kawasaki disease patients were followed for more than 10 years from disease onset. The 33 patients comprised four groups: group 1 included 13 Kawasaki disease patients with a total of 23 sites of regressed large sized (>/= 4 mm) coronary aneurysms; group 2 included 13 Kawasaki disease patients with 22 sites of regressed small sized (< 4 mm) coronary aneurysms (four patients had sites of both large and small sized aneurysms); group 3 included a further five Kawasaki disease patients with 25 normal coronary angiography sites in the acute stage of Kawasaki disease; and group 4 comprised the six patients with congenital heart disease as controls, with a total of 27 normal coronary angiography sites. During coronary angiography, 15 microg of acetylcholine and 0.5 mg isosorbide dinitrate were infused into the coronary artery. The luminal diameter at the sites was measured using a cine-videodensitometric analyser, to assess the distensibility of the coronary artery wall.
RESULTS: Coronary angiography in all 22 patients in groups 1 and 2 and in all the patients in group 3 was normal, with no stenoses and no irregularity of the arterial wall. However, the intravascular ultrasound imaging in groups 1 and 2 showed various degrees of the intimal thickening. In groups 1 and 2, there was significantly more vascular constriction with acetylcholine, and poorer dilatation with isosorbide dinitrate than in groups 3 or 4 (each p < 0.05, respectively). There was no difference between group 3 and group 4 in response to either acetylcholine or isosorbide dinitrate,
CONCLUSIONS: There is evidence of persisting abnormal vascular wall morphology and vascular dysfunction at the site of regressed coronary aneurysms in patients with previous Kawasaki disease. These patients should be counselled to avoid potential risk factors for atherosclerosis, and long term follow up is needed into adult life.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677411      PMCID: PMC1729327          DOI: 10.1136/heart.83.3.307

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  28 in total

1.  Endothelial dysfunction late after Kawasaki disease.

Authors:  R Dhillon; P Clarkson; A E Donald; A J Powe; M Nash; V Novelli; M J Dillon; J E Deanfield
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

2.  Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine.

Authors:  R Yamakawa; M Ishii; T Sugimura; T Akagi; G Eto; M Iemura; T Tsutsumi; H Kato
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

Review 3.  Kawasaki disease.

Authors:  H Kato; T Akagi; T Sugimura; N Sato; T Kazue; K Hashino; A Nishiyori; M Sakaguchi
Journal:  Coron Artery Dis       Date:  1995-03       Impact factor: 1.439

4.  Fate of coronary arterial aneurysms in Kawasaki disease.

Authors:  A Suzuki; T Kamiya; Y Arakaki; Y Kinoshita; K Kimura
Journal:  Am J Cardiol       Date:  1994-10-15       Impact factor: 2.778

5.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

6.  Impaired endothelial function in epicardial coronary arteries after Kawasaki disease.

Authors:  Y Mitani; Y Okuda; H Shimpo; F Uchida; K Hamanaka; K Aoki; M Sakurai
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

Review 7.  Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators.

Authors:  M Feelisch
Journal:  Eur Heart J       Date:  1993-11       Impact factor: 29.983

8.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

9.  Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound.

Authors:  A Suzuki; M Yamagishi; K Kimura; H Sugiyama; Y Arakaki; T Kamiya; K Miyatake
Journal:  J Am Coll Cardiol       Date:  1996-02       Impact factor: 24.094

10.  Evaluation of pulmonary artery histopathologic findings in congenital heart disease: an in vitro study using intravascular ultrasound imaging.

Authors:  M Ishii; H Kato; T Kawano; T Akagi; Y Maeno; T Sugimura; K Hashino; T Takagishi
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

View more
  51 in total

Review 1.  Kawasaki disease in the adult: a case report and review of the literature.

Authors:  Juan Carlos Rozo; John L Jefferies; Benjamin W Eidem; Patrick J Cook
Journal:  Tex Heart Inst J       Date:  2004

2.  Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome.

Authors:  Pauline Gatterre; Mehdi Oualha; Laurent Dupic; Franck Iserin; Christine Bodemer; Fabrice Lesage; Philippe Hubert
Journal:  Intensive Care Med       Date:  2012-01-25       Impact factor: 17.440

3.  Endothelial dysfunction in adult patients with a history of Kawasaki disease.

Authors:  Ayumi Niboshi; Kenji Hamaoka; Koichi Sakata; Nozomi Yamaguchi
Journal:  Eur J Pediatr       Date:  2007-03-08       Impact factor: 3.183

4.  Mid-term Risk for Subclinical Atherosclerosis and Chronic Myocarditis in Children with Kawasaki Disease and Transient Coronary Abnormalities.

Authors:  Mansingh Parihar; Surjit Singh; Pandiarajan Vignesh; Anju Gupta; Manojkumar Rohit
Journal:  Pediatr Cardiol       Date:  2017-05-17       Impact factor: 1.655

5.  Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.

Authors:  Y F Cheung; M H K Ho; S C F Tam; T C Yung
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

Review 6.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

7.  Recognizing Kawasaki disease.

Authors:  B Lang
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

8.  Myocardial blood flow and coronary flow reserve in children with "normal" epicardial coronary arteries after the onset of Kawasaki disease assessed by positron emission tomography.

Authors:  M Hauser; F Bengel; A Kuehn; S Nekolla; H Kaemmerer; M Schwaiger; J Hess
Journal:  Pediatr Cardiol       Date:  2003-12-15       Impact factor: 1.655

9.  Arterial stiffness in the young: assessment, determinants, and implications.

Authors:  Yiu-Fai Cheung
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

10.  Carotid intima-media thickness and pulse wave velocity after recovery from kawasaki disease.

Authors:  Soo Jin Lee; Hye Mi Ahn; Jung Hyun You; Young Mi Hong
Journal:  Korean Circ J       Date:  2009-07-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.